Most recently, it has been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to your big range of endogenous opioids. Compared with most opioid receptors, this receptor functions to be a scavenger https://peterj643hij3.blazingblog.com/profile